Edge Pharma, LLC recalls Lidocaine HCl Sterile Buffered Solution for Injection (PF) 1%, 10mL per syringe, Single Use Syringe for Infiltration and
Recalled February 2, 2022 · FDA recall D-0395-2022 · Edge Pharma
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
4465 syringes
Sold at
nationwide
Description
Lack of Assurance of Sterility
Product
Lidocaine HCl Sterile Buffered Solution for Injection (PF) 1%, 10mL per syringe, Single Use Syringe for Infiltration and Nerve Block, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-0850-10
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →